WCM
MED icon

Wedge Capital Management’s Medifast MED Stock Holding History

Wedge Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,629
Closed -$1.53M – 510
2023
Q2 		$1.53M Buy
+16,629
New +$1.48M 0.02% 396
2018
Q2 		– Sell
-15,964
Closed -$1.49M – 601
2018
Q1 		$1.49M Sell
15,964
-6,136
-28% -$458K 0.01% 294
2017
Q4 		$1.54M Sell
22,100
-1,100
-5% -$73K 0.01% 301
2017
Q3 		$1.38M Sell
23,200
-7,100
-23% -$353K 0.01% 320
2017
Q2 		$1.26M Hold
30,300
– – 0.01% 306
2017
Q1 		$1.34M Sell
30,300
-1,100
-4% -$47.3K 0.01% 286
2016
Q4 		$1.31M Buy
31,400
+15,700
+100% +$632K 0.01% 298
2016
Q3 		$593K Buy
+15,700
New +$563K 0.01% 409

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wedge Capital Management's MED Position: Q3 2023 in Review

Wedge Capital Management sold out of Medifast (MED) in Q3 2023, closing a stake of 16,629 shares — an estimated $1.53M sold.

Wedge Capital Management first reported a position in MED in Q3 2016 and held it in 8 quarters. The position peaked at $1.54M in Q4 2017. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

  • Wedge Capital Management reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
  • Wedge Capital Management sold 16,629 Medifast shares in Q3 2023, an estimated $1.53M.
  • Wedge Capital Management first reported a position in Medifast in Q3 2016 and held it in 8 quarters.
  • Wedge Capital Management's Medifast position peaked at $1.54M in Q4 2017.
  • 223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Wedge Capital Management's 13F filing for Q3 2023, filed 13 Oct 2023.